Manufacturers Life Insurance Company, The Trevena Inc Transaction History

Manufacturers Life Insurance Company, The

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.5 $10,931 - $27,329	-54,659 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$0.41 - $0.63 $22,410 - $34,435	54,659 New	54,659 $30,000
Q1 2022 May 20, 2022	SELL	$0.41 - $0.63 $2,553 - $3,923	-6,227 Reduced 10.23%	54,659 $30,000
Q4 2021 Feb 16, 2022	SELL	$0.57 - $1.29 $6,430 - $14,552	-11,281 Reduced 15.63%	60,886 $35,000
Q3 2021 Nov 12, 2021	SELL	$1.11 - $1.7 $35,177 - $53,874	-31,691 Reduced 30.51%	72,167 $89,000
Q2 2021 Aug 12, 2021	BUY	$1.46 - $2.25 $151,632 - $233,680	103,858 New	103,858 $176,000
Q3 2018 Nov 14, 2018	SELL	$1.39 - $2.25 $589 - $954	-424 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$1.51 - $2.06 $15,608 - $21,294	-10,337 Reduced 96.06%	424 $1,000
Q4 2017 Feb 08, 2018	BUY	$1.4 - $2.6 $10,344 - $19,211	7,389 Added 219.13%	10,761 $18,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.79 $7,485 - $9,407	3,372	3,372 $9,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.